New anticoagulants
- 1 August 2001
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 142 (2) , S3-S8
- https://doi.org/10.1067/mhj.2001.117031
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Melagatran, a Novel Synthetic LMW Thrombin Inhibitor, in Patients with Acute DVTThrombosis and Haemostasis, 1999
- Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic EnzymesThrombosis and Haemostasis, 1998
- A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip ReplacementNew England Journal of Medicine, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)Circulation, 1994
- Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.Circulation, 1994
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- HeparinNew England Journal of Medicine, 1991
- Kinetics of the inhibition of thrombin by hirudinBiochemistry, 1986